Back to mobile site

Celgene (CELG) Remains In The Good Graces of Oppenheimer

October 27, 2017 11:09 AM EDT Send to a Friend
Oppenheimer maintains Outperform on Celgene (NASDAQ: CELG) price target of $163.00.Analyst Leah Rush Cann likes the highly ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login